Mature Resting Ly6C(high) Natural Killer Cells Can Be Reactivated by IL-15
Overview
Affiliations
Mature NK cells are heterogeneous as to their expression levels of cell surface molecules. However, the functional differences and physiological roles of each NK-cell subset are not fully understood. In this study, we report that based on the Ly6C expression levels, mature C57BL/6 murine NK cells can be subdivided into Ly6C(low) and Ly6C(high) subsets. Ly6C(high) NK cells are in an inert state as evidenced by the production of lower levels of IFN-γ and granzyme B, and they exhibit poorer proliferative potential than Ly6C(low) NK cells. In addition, adoptive transfer experiments revealed that Ly6C(high) NK cells are derived from Ly6C(low) NK cells in the steady state. These results strongly suggest that Ly6C(high) NK cells are resting cells in the steady state. However, in vitro, Ly6C(high) NK cells become Ly6C(low) NK cells with strong effector functions upon stimulation with IL-15. Moreover, Ly6C(high) NK cells also revert to Ly6C(low) NK cells in vivo upon injection of the IL-15 inducers polyI:C and CpG. Taken together, these results demonstrate the plasticity of mature NK cells and suggest that Ly6C(high) NK cells are a reservoir of potential NK cells that allow effective and strong response to infections.
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform.
Alles M, Gunasena M, Isckarus C, De Silva I, Board S, Mulhern W NPJ Vaccines. 2025; 10(1):5.
PMID: 39799133 PMC: 11724931. DOI: 10.1038/s41541-024-01053-1.
Liu B, Li F, Wang Y, Gao X, Li Y, Wang Y Front Pharmacol. 2024; 15:1437113.
PMID: 39351084 PMC: 11439715. DOI: 10.3389/fphar.2024.1437113.
Sahu B, Nookala S, Floden A, Ambhore N, Sathish V, Klug M Brain Behav Immun. 2024; 121:365-383.
PMID: 39084541 PMC: 11442016. DOI: 10.1016/j.bbi.2024.07.038.
Kare A, Nichols L, Zermeno R, Raie M, Tumbale S, Ferrara K Cytometry A. 2023; 103(11):839-850.
PMID: 37768325 PMC: 10843696. DOI: 10.1002/cyto.a.24788.
Wu Y, Kissner M, Momen-Heravi F J Immunol Methods. 2023; 515:113444.
PMID: 36868498 PMC: 10508641. DOI: 10.1016/j.jim.2023.113444.